Tech Founders for Garvan will be attended by:
Mr Nick Abrahams
- Board member, Garvan Research Foundation
- Global Head of Technology and Innovation at Norton Rose Fulbright and has deep commercial expertise and global networks in the technology space.
- Founder of leading online legal site, LawPath.
- Non-executive director on ASX300 software company, Integrated Research.
- Director of the Sydney Film Festival and is on the board of the Vodafone Foundation, and is past President of the Australian Communications and Media Law Association.
- Writes regularly on technology and future trends for The Australian Financial Review.
Mr Ashik Ahmed
- Ashik Ahmed is the Cofounder & CEO of tech startup Deputy, a workforce management platform headquartered in Sydney, Australia.
- Deputy is used by more than 250,000 workplaces in more than 100 countries to schedule, communicate with and ensure labor compliance standards are adhered to for more than 1 million shift workers across the globe using our platform.
- Ashik leads a global team whose mission is to simplify shift work, whilst working towards a vision of thriving workplaces in every community.
- A regular contributor to Forbes magazine Ashik is also an expert on the subjects of workforce management, HR tech, machine learning, linear optimisation and crypto.
Mr Roger Allen
- Mr Roger Allen AM is a well-known entrepreneur, venture capitalist and social impact investor and philanthropist whose global career has spanned over 50 years.
- Allen helped pioneer the Australian technology industry through the Computer Power Group, one of the first, Australian founded, tech companies to scale globally and subsequently IPO turning over approx. $1B in today’s currency.
- Following the company’s acquisition in 1995, Allen co-founded Allen & Buckeridge Pty Ltd; the original early stage venture capital firm, raising over $300m to seed and support over 50 start-up companies over the life of its funds.
- After helping establish two successor VC firms, Allen in 2007 and has since focused on his private VC portfolio of over 40 companies and social impact investments.
- Allen has established a Public Benevolent Institute called Indigenous Capital Limited (ICL) to focus on indigenous economic development by applying the experience of the tech industry. Programs include facilitating start up best practise through a national network of incubators with access to a range of financial products including an indigenous VC Fund.
- ICL has used technology to create an ecommerce marketplace for indigenous experiences, knowledge and products www.welcometocountry.com
Mr David Barda
- An entrepreneur, executive and advisor specialising in technology commercialisation and early stage ventures for biomedical technologies.
- Director for Business Development and Innovation at the Garvan Institute of Medical Research.
- Previously led a team commercialising medical technologies in Singapore with A*STAR, the national science and technology agency.
- Many years of experience founding and consulting to new ventures in the life sciences area with companies such as Anatomics, Saluda Medical and Simavita.
- Has an Honours degree in Computer Science from UNSW and has a Masters of Intellectual Property Law from Monash University and is an inventor on 24 granted patents.
- Interest areas include business models for precision medicine, AI for healthcare, genomics, bioinformatics, medical IOT, brain-computer interface, bioelectronic medicine, medical imaging and wearable sensors.
Mr Alex Badran
- Co-CEO and Co-Founder of Spriggy, a finance app that allows parents to give their children pocket money digitally, by loading cash onto a prepaid card. It also teaches children how to manage their money.
- Spriggy received backing from Mike Cannon-Brookes (Jr), via his investment venture, Grok Ventures.
- The start-up was named as an emerging fintech star in the KPMG Fintech and H2 Ventures Fintech 100 list.
- Non-executive director at Stone & Chalk until 2015 (a network bringing together founders & investors).
- Alex completed a PhD in Mathematics at The University of Sydney in 2014.
Mr Riad Chikhani
- Founder and CEO of the GAMURS Group, a leading esports media network with a global team reaching hundreds of millions of gamers per month.
- Forbes 30 under 30 CEO. Riad built his first game by the time he was 12 by teaching himself Java and went on to teach himself PHP, MySQL, HTML and CSS at 14 years of age.
- Advisor at ACT Capital Partners, investment management focused on acquisition of the next generation of media companies.
- Founded his first business Rune Gear at the age of 14, a gaming online community, which he sold at 17.
Mr Andrew Clarke
- Entrepreneur and Founder of Cashrewards, Australia’s largest cashback platform, where users get a portion of their cashback when making a purchase online or in-store at more than 1,600 retailers, including Amazon, Apple, Myer, David Jones, Dan Murphy's, Microsoft and Booking.com.
- Over $2 billion dollars in revenue generated for retail partners since launch in 2014.
- In addition to helping Australians save money on their shopping, The Starlight Children’s Foundation receive a donation every time shoppers earn cashback.
- Cashrewards is also a partner of Pledge 1%, a corporate philanthropy movement pioneered by Salesforce and Atlassian.
Mr Michael Cannon-Brookes (Sr)
- Board member, Garvan Research Foundation
- Director of Cannon-Brookes Consulting Pty Ltd, and a CEO level executive coach with Foresight Global Coaching.
- Established Citibank in Australia in 1985.
- Retired from IBM in July 2012, where he was IBM’s Vice President, Global Strategy for Growth Markets, based in Shanghai, China.
- Graduated with Honours in Law from Cambridge University.
- He was elected a Global Board Member of Advance in 2013, and in the same year a Fellow of the Australian Institute of Company Directors.
Ms Topaz Conway
- Non-executive Director at: Neuraura Inc, Omni Tanker Pty Ltd, Cicada Innovations and UTS Foundation.
- Professor of Practice at UNSW Business School.
- Works with early stage founders and their companies on commercialisation and investment strategies.
- Entrepreneur, director and angel investor.
Mr Robbie Cooke
- CEO and Managing Director of Tyro Payments.
- Formerly Managing Director and CEO of Tatts Group, a role which concluded upon the successful merger with Tabcorp in December 2017.
- Prior to that, he served first as COO, and then as Managing Director and CEO, of Wotif.com over a seven-year period. During that time, Wotif.com scaled up significantly, achieved a circa five-fold increase in profits and undertook a successful ASX listing.
Mr Phil Copeland
- Co-Founder and former CEO of Avoka
- Avoka developed a software platform – ‘Avoka Transact’ enabling banks to rapidly create outstanding customer journeys for sales and onboarding.
- Sold Avoka in 2018 for $US 245M to Temenos – the world’s leading banking software company.
- Currently Executive Chairman Nitric – a new Australian startup building a Virtual Cloud Platform (VCP) enabling the development of applications that are portable across any cloud or on-premise environment.
Prof Chris Goodnow
- Internationally renowned immunologist and recipient of The Bill & Patricia Ritchie Foundation Chair.
- Joined Garvan in 2015 as Deputy Director, after an extensive research career including faculty positions at Stanford University and the Australian National University and has been closely involved in several biotechnology start-up companies. Has been Director of Garvan since 2018.
- Pioneered the integration of molecular genetics and genomics with immunology to reveal how the immune system distinguishes between ‘self’ and ‘non-self’ for which he received numerous awards and election to the Australian Academy of Science, the UK Royal Society and the US National Academy of Science.
Mr Scott Farquhar
- Co-Founder and Co-CEO of Atlassian, a collaboration software company that helps teams organise, discuss and complete shared work. More than 200,000 large and small organisations, NFPs, and government agencies across the world, including companies like ANZ bank, Spotify, Twilio, Mercy Ships and Visa use Atlassian’s collaboration products to help their teams work better together.
- Co-Founder Pledge 1%, a corporate philanthropy movement dedicated to making the community a key stakeholder in every business.
- Youngest person ever to be awarded the ‘Australian Entrepreneur of the Year’ in 2006 by Ernst & Young alongside Co-Founder and Co-CEO Mike Cannon-Brookes and in 2017 Forbes named them on their ‘Global Game Changers’ list.
- Outside of Atlassian, Scott co-founded a private investment fund, Skip Capital, which focuses on fast-growing technology companies, with a particular interest in the intersection of big data and health.
- BSc (Business Information Technology) from the University of New South Wales.
Mr Steve Cuda
- Chief Product and Marketing Officer at Cashrewards.
- Previous GM of digital, media and data at Woolies X, Woolworths’ digital, e-commerce, customer loyalty and customer services division (from 2015 to 2020).
- Previous Head of Membership and Marketing at the NRMA.
Mr Bill Ferris AC
Bill Ferris created Australia’s first venture capital firm in 1970 and is the Co-Founder with Joe Skrzynski of CPE Capital, formerly named CHAMP Private Equity Group. In March 2020, Bill was appointed Chair of the Medical Research Commercialisation Fund, Australia’s largest venture capital investor in the life sciences sector.
- Bill was the inaugural Chair of Innovation and Science Australia from 2015 to 2018 which provided the report to Government entitled “Australia 2030 – Prosperity through Innovation”.
- Bill’s former directorships include: Chair - Australian Trade Commission (Austrade); Chair - Garvan Institute of Medical Research; Chair - Federal Government’s Health and Hospitals Fund Advisory Board; Chair - Accolade Wines Australia and UK; Chair - Austar United Communications; Director - Macquarie University Asia Pacific Council; Director - Garvan Research Foundation; Director - Austal Ltd; Director – Australian Institute of Management (NSW) Ltd; Expert Panel Member of the Federal Government’s Strategic Review of Health and Medical Research; Former Member of the Harvard Business School Asia Pacific Advisory Council.
- Bill was awarded an Officer of the Order of Australia in 1990 for services to the export industry and in 2008 was made Companion in the Order of Australia for his philanthropic activities, as a leader in support of medical research and his role in the establishment of the private equity sector in Australia.
Mr Mark Fordree
- Founder and Executive Director of Ignition Advice.
- Has global experience across funds management, stock broking, corporate advisory and venture capital gained through a number of C-level roles at leading financial institutions such as Potter Warburg (UBS), ANZ Bank and ABN AMRO.
- Has also successfully founded two start-ups focused on technology and disruption and serves as a key member on both boards.
Dr Richard George
- Dr Richard George is co-founder and Chief Data Scientist at Faethm AI. Faethm's AI SaaS platform models the evolution of work brought about by the disruptive effects of emerging technology. Faethm helps governments and companies around the world to prepare their workforce for the future.
- PhD in bioinformatics from University College London
- Postdoctoral positions at Inpharmatica – Europe’s first AI biotech - and the Victor Chang Cardiac Research Institute
- MBA from the AGSM and Tuck School of Business, Dartmouth College
- Founding partner of a drug-discovery start-up and other ventures
- Ten years in strategy consulting and senior management
- Managed the integration of Quantium’s data science while leading Advanced Analytics at Woolworths
Mr Michael Giles
- Chief Technology Officer, Founder and Director of Ignition Advice.
- Has 30 years’ experience in financial services software development during which time he has managed and built solutions in Australia, UK and the US for CBA, Westpac, Barclays, Lloyds and Microsoft.
- He is a serial entrepreneur and has previously founded, scaled and exited two enterprise technology companies, Invisic to Portera Systems (Silicon Valley in 2002) and WealthPoint (to ING Asia Pac in 2006).
Dr Susan Graham
- CEO and Co-Founder of Dendra Systems, an environmental services company that uses drone technology to survey and analyse degraded land, and to plot trees to restore the ecosystems.
- Graduated from the University of Oxford with a PhD in Biomedical Engineering in 2015.
- Named on the Forbes 30 under 30 list for industry in Europe in 2017 and is the former winner of both the 2015 Hello Tomorrow Competition Grand Prize and the 2017 New York Venture Summit Pitch Competition.
- Winner of the Advance Award for Emerging Leaders, which recognises Global Australians who represent the next generation of Australian innovators, thought leaders, creators and collaborators
Mr Rajeev Gupta
- Partner of Alium Capital Management, a cross-over investment fund which invests in technology and innovation, domestically and internationally. Invests in early stage businesses, all the way through to publicly listed assets.
- Exit in GeckoLife, a platform for groups and individuals to communicate and collaborate.
- Prior to this, Rajeev was a Director at Goldman Sachs and Tribeca Global, investment management and financial services firms.
Mr Chris Hadley
- Executive Chairman at Quadrant Private Equity
- Existing Quadrant portfolio companies include: RiteBite Group, Junior Adventures group, Probe Group, QMS Media, Total Drain Group, MYMC, Fullerton Health, Journey Beyond, to cite only a few.
- Exited Quadrant portfolio companies include: Canberra Data Centres, Icon Cancer Care, The Real pet Food Company, Qscan and APM.
- Director of Quadrant investee companies: RiteBite Group, Fitness and Lifestyle Group, The Education and Entertainment Group, Superior Food Group and A-Mart.
- Quadrant secured 10th place in the HEC-DowJones Private Equity Performance Ranking report (published at the end of January) - the survey included 529 Private Equity firms and focussed on those that have generated the best performance for their investors over the past years.
- Quadrant recently secured $1.24 billion buy-out fund, making it the fourth-largest Australia-focused buy-out fund raised in the past five years.
- Director of Communications, Office of the CEOs/Founders at Atlassian.
- Previously Head of APAC Communications at Atlassian covering Australia, Japan and India markets.
- Prior to joining Atlassian, Louise worked at OPR agency as a Senior Communications Manager, and as a Communications Consultant for NAB
- Louise has a BA in Public Communications from UTS.
A/Prof Sarah Kummerfeld
- Scientific Head of Garvan’s Kinghorn Centre for Clinical Genomics.
- Uses genomics to understand human disease and translate findings into clinical diagnostics and treatments.
- Completed her PhD in Computational Biology at the University of Cambridge, working on protein structure and function prediction; during her postdoctoral research at Stanford University she studied the molecular basis of human ageing.
- Has worked both in academia and industry, including 10 years as a scientist at Genentech, based in the San Francisco Bay area. At Genentech, she used large-scale genomics approaches to understand why only some patients respond to treatment and to identify diagnostic biomarkers that predict response to particular drugs.
Mr David Masters
- David Masters is the Director of Global Public Policy at Atlassian.
- Prior to this role he was the Corporate Affairs Director at Microsoft Australia and is currently the Chair of the Information and Communication Technology Industry Reference Committee.
- David has previously held the position of ICT Practice Director for public affairs consultancy Parker & Partners and has worked for the Australian Government as a senior public servant/adviser on a range of ICT policy issues.
Dr Daniel MacArthur
- Director of Garvan’s new Centre for Population Genomics, established in partnership with Murdoch Children’s Research Institute, to solve the critical scientific, regulatory and technical problems currently limiting the development of genomic medicine in Australia, and execute large-scale projects that will establish Australia’s leadership in this field.
- Previously served as Co-Director of the Medical and Population Genetics Program at the Broad Institute of MIT and Harvard, and headed up a team jointly based at the Broad Institute, Massachusetts General Hospital and Harvard Medical School.
- Co-directed the Broad Institute's Center for Mendelian Genomics, which has sequenced and analysed genomic data from more than 10,000 individuals from rare disease families and contributed to the discovery of more than 100 new rare disease genes.
- Led the development of the Genome Aggregation Database (gnomAD), the largest and most widely used data set of human exome and genome sequence data, which has collated data from more than 140,000 sequenced individuals.
Mr Adam McCurdie
- Humanitix received funding from the Atlassian Foundation and NSW Government. In 2018, the company won the Google Impact Challenge and is now doubling in size every 6 months.
- Director at Ripple Capital (2015 - 2018), providing financial help for refugees and asylum seekers to start their own business.
- Prior to this Adam was a management consultant with Accenture and a Lecturer/Tutor at The University of Sydney Business School.
Mr Nat McGregor
- Mr McGregor joins Garvan as Chief Operating Officer in 2020.
- He has over 20 years’ experience in financial and organisational leadership including holding the position of University of Newcastle Chief Operating Officer since 2013.
- Holds a Bachelor of Commerce (University of Newcastle), is CPA qualified, an MBA from Deakin University and is an alumni of both INSEAD and Columbia University business schools.
- He also was an alternate Independent Director and Member of the Audit and Risk Committee for the Hunter Medical Research Institute and played a role in establishing the new Central Coast Research Institute.
Mr Hamish McLennan
- Mr McLennan is a media and marketing industry executive with over 30 years of experience
- He is the new Chairman of Rugby Australia, Chairman of REA Group, Chairman of HT&E and a non-executive director of Magellan Financial group.
- He was Executive Chairman and Chief Executive Officer of Ten Network Holdings until July 2015 and prior to this he was Executive Vice President, Office of the Chairman, at News Corp (formerly News Corporation).
- Mr McLennan has also held the role of global Chairman of Young & Rubicam, part of WPP, the world’s largest communications services group. In 2017, he joined technology start-up Tiger Pistol in an advisory capacity. He has previously served on the Board of Directors for the United Negro College Fund (UNCF) and the US Ad Council.
Mr John Meacock
- Freelance Global Adviser and Non-executive Director; is a highly influential leader experienced at leading, growing and innovating business on a global stage. He has deep cross-industry expertise in strategy, risk, finance, technology impact, innovation, geopolitics and governance.
- Global Chief Strategy Officer at Deloitte from 2002 to 2018.
- Partner at PwC from 2000 to 2001.
Mr Daniel Milham
- Co-Founder and Director of Koala, an Australian start-up delivering high-quality furniture.
- Non-Executive Director of Fishburners, a large start-up community helping start-ups start, grow and succeed.
- Also, the Founder and Partner of DROPBEAR, an early stage venture fund and consumer brand studio
Mr Daniel Petre AO
- Partner at AirTree Ventures, an early and growth-stage venture capital fund. AirTree Ventures raised more than $700m to invest in high-growth businesses that are utilising technology to disrupt markets and provide compelling new products.
- Daniel was previously the Founding Chairman of Netus, a technology investment company acquired by Fairfax Media in 2013, and before that he founded Australia's largest internet investment company, Ecorp, (a subsidiary of PBL; Publishing and Broadcasting Limited).
- Spent nine years with Microsoft where he held a range of roles both in Australia and the US.
- Adjunct Professor at UNSW Sydney, School of Business and the School of Taxation and Business Law.
- Has held a number of board positions, at the Department of Industry, Innovation and Science, the Sydney Theatre Company and Garvan between 2011 and 2016. Former Board and Chair of the Sydney Children’s Hospital Network.
A/Prof Joseph Powell
- Head of the Garvan-Weizmann Centre for Cellular Genomics, a Lab Head at Garvan Institute of Medical Research and a Principal Research Fellow in the Faculty of Medicine, UNSW Sydney.
- Obtained his PhD from the University of Edinburgh in 2010 while a member of the scientific advisory board at Aviagen.
- Following his PhD, he moved to Professor Peter Visscher’s (FRS, FAA) group at QIMR, and then the University of Queensland and helped form and lead an international consortium to study the genetic control of gene expression, the Consortium for the Architecture of Gene Expression (CAGE).
- In 2015, he started his own group at the Institute for Molecular Bioscience, where they pioneered the use of single-cell sequencing methods to understand the genetic control of disease and cell development.
- A founding director of SeqBio, a company developing new diagnostic technology for lung diseases using liquid biopsies and single-cell sequencing.
Mr Dominic Price
- An accomplished TED speaker, Dom is proud to work at Atlassian, the home of the most intelligent t-shirt wearers in business. As our resident Work Futurist. Dom is our in house “Team Doctor” helping Atlassian scale by being ruthlessly efficient and effective, and spends over half his time helping our customers navigate transformation, agility, and the future of work.
- Dom helped pioneer our Team Playbook and has a deep passion for understanding of teamwork and the changes we need to make today to build thriving businesses.
- He has previously been the GM Program Management for a global gaming company and a Director of Deloitte.
Mr Josh Ross
- Co-Founder of Humanitix, the first not-for-profit ticketing platform that directs 100% of the booking fees to education projects.
- Previously was Partner/Senior Investment Analyst (Global Equities) at Watermark Funds Management.
- Has a Bachelor of Applied Finance and Commerce from Macquarie University.
Mr Russell Scrimshaw
- Chairman of the Garvan Research Foundation Board.
- Was until recently the Non-Executive Chairman of UK listed Sirius Minerals Plc, and is currently Non-Executive Chairman of Tech Project Group P/L and the Executive Chairman of Torrus Capital P/L, the Australian Philanthropic Fund, the Scrimshaw Foundation and Scrimshaw Nominees P/L.
- Previously held executive positions at Fortescue Metals Group Ltd (FMG), Commonwealth Bank, Optus and IBM. He was also a Non-Executive Board Director for Commonwealth Properties Ltd, EDS Australia, Mobilesoft Ltd, Telecom New Zealand Australia P/L and Athletics Australia.
Mr Nimesh Shah
- Chief Financial Officer at ReadyTech, a leading provider of software for the education and employment sector. It is backed by Pemba capital Partners.
- Was previously Chief Financial Officer at Isentia, a media intelligence company and Finance Director at Fairfax digital
- Is on the Board of Directors for Rugby League Players.
- Has an MBA from AGSM and Chartered accountant
Ms Mara-Jean Tilley
- Director of the Garvan Research Foundation, the marketing and fundraising arm of the Garvan Institute of Medical Research.
- Formerly the Director of Philanthropy, Bequests and Campaigns, she commenced working at Garvan in 2011.
Prior to joining Garvan, she was the Foundation Executive at the Sydney Theatre Company where she held a variety of positions over more than 8 years with the organisation.
Mr Howard Treisman
- Currently on a sabbatical, Howard was CTO and Co-Founder of Avoka Technologies.
- Avoka was founded in 2002, and expanded into Europe and North America. Avoka was purchased by Temenos, a European banking system provider, in December 2018.
- Previously, Howard held technical and leadership roles at Jarrah Technologies, SpotOn, Open Environment and Borland.
Mr Gavin Whyte
- Chief Artificial Intelligence Officer at Public Sector Network, BrewAI.
- BrewAI is a deep-learning automl product, with no coding required. With just a excel spreadsheet you can build an optimised neural network, predictive engine in hours ready for production.
- Ex Honorary Associate at the University of Technology Sydney.
- Previously was Chief Data Scientist and Principal at Deloitte.
Mr Blake Wills
- Blake is a proven company executive with experience in the finance, life sciences and education sectors.
- Previously the Chief Operating Officer of an ASX-listed company, he brings substantial operational, financial and governance experience to Microba as founding CEO. His financial background combined with his extensive operational expertise has driven Microba forward as a thriving company with more than 40 full-time employees.
- Blake’s experience in executing multiple international acquisitions and the management of new product and service builds has given him the skills to provide Microba’s world-leading technology to people globally.
- Holds a Master of Business (Professional Accounting), Bachelor of Finance (Hons) and Bachelor of Business (Finance) from the Queensland University of Technology.
Mr Bernard Wilson
- Chief Executive Officer of Cashrewards in July 2020.
- Bernard has over seven years’ experience leveraging data assets and marketing technology to drive competitive advantage for businesses through marketing and digital transformation, loyalty proposition optimisation, and data and media commercialisation.
- Prior to joining Cashrewards, Bernard was an executive at Quantium, a leading data science and artificial intelligence company, heading Quantium’s Open Banking and FinTech business.
- Held senior management positions at Myer and Woolworths.
- Bernard was also a Vice President at Investment Bank Credit Suisse and a lawyer at King & Wood Mallesons.
- Holds a Bachelor of Arts / Law (First Class Honours) from Sydney University and is a member of the Australian Institute of Company Directors.